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Terpenoid indole alkaloid (TIA) biosynthesis in Catharanthus roseus is a complex and
highly regulated process. Understanding the biochemistry and regulation of the TIA
pathway is of particular interest as it may allow the engineering of plants to accumulate
higher levels of pharmaceutically important alkaloids. Toward this end, we generated
a transgenic C. roseus hairy root line that overexpresses the CrBPF1 transcriptional
activator under the control of a β-estradiol inducible promoter. CrBPF1 is a MYB-
like protein that was previously postulated to help regulate the expression of the TIA
biosynthetic gene STR. However, the role of CrBPF1 in regulation of the TIA and related
pathways had not been previously characterized. In this study, transcriptional profiling
revealed that overexpression of CrBPF1 results in increased transcript levels for genes
from both the indole and terpenoid biosynthetic pathways that provide precursors for
TIA biosynthesis, as well as for genes in the TIA biosynthetic pathway. In addition,
overexpression of CrBPF1 causes increases in the transcript levels for 11 out of 13
genes postulated to act as transcriptional regulators of genes from the TIA and TIA
feeder pathways. Interestingly, overexpression of CrBPF1 causes increased transcript
levels for both TIA transcriptional activators and repressors. Despite the fact thatCrBPF1
overexpression affects transcript levels of a large percentage of TIA biosynthetic and
regulatory genes, CrBPF1 overexpression has only very modest effects on the levels
of the TIA metabolites analyzed. This finding may be due, at least in part, to the up-
regulation of both transcriptional activators and repressors in response to CrBPF1
overexpression, suggesting that CrBPF1 may serve as a “fine-tune” regulator for TIA
biosynthesis, acting to help regulate the timing and amplitude of TIA gene expression.
Keywords: Catharanthus roseus, CrBPF1, GBF, ORCA2, ORCA3, terpenoid indole alkaloid, transgenic hairy roots,
ZCT
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Introduction
Madagascar periwinkle Catharanthus roseus (L.) G. Don is of
substantial pharmaceutical interest as it produces over 130
terpenoid indole alkaloids (TIAs). Several of these TIAs are used
to treat diﬀerent medical conditions. For example, vinblastine
and vincristine are widely used as anticancer agents in the
treatment of lymphoma and leukemia (Gidding et al., 1999) and
ajmalicine and serpentine may be used to treat hypertension.
Unfortunately these plant-derived pharmaceutical compounds
are very expensive as periwinkle produces TIAs in very low
amounts. In addition, due to their complex chemical structures,
TIAs tend to be diﬃcult, and therefore expensive, to synthesize
in vitro. To lower the costs of producing TIAs for use as
pharmaceuticals, many eﬀorts have been made to increase TIA
production using plant tissue and cell cultures or bacterial
cultures. However, despite eﬀorts since the early 1980s to develop
cost-eﬀective methods for large-scale production of TIAs in
cultures or in vitro, progress has been limited (van der Heijden
et al., 2004; Shanks, 2005).
A major reason why these eﬀorts have not been more
successful is that the TIA biosynthetic pathway and the
regulation of the TIA pathway and TIA feeder pathways
are not suﬃciently well understood. Those deﬁciencies are
beginning to be addressed, thanks to progress in identifying
most of the genes encoding TIA biosynthetic enzymes and
transcriptional regulators (Liu et al., 2007; Memelink and Gantet,
2007; Zhou et al., 2010a; Giddings et al., 2011; Asada et al.,
2013; Besseau et al., 2013; Salim et al., 2013; Zhao et al.,
2013; De Luca et al., 2014; Kellner et al., 2015; Qu et al.,
2015; Van Moerkercke et al., 2015). TIA biosynthesis is a
closely coordinated process involving many enzymatic steps
that occur in several intra- and inter-cellular compartments
(Burlat et al., 2004; van der Heijden et al., 2004; Murata et al.,
2008; De Luca et al., 2014; Qu et al., 2015). TIA biosynthesis
in C. roseus starts with the formation of strictosidine from
tryptamine and secologanin, the two precursor molecules that
are produced by the indole and the monoterpenoid pathways,
respectively (Figure 1). The condensation process is catalyzed by
strictosidine synthase (STR). Strictosidine is then deglucosylated
by strictosidine β-D-glucosidase (SGD) to form strictosidine
aglycone. Further enzymatic steps result in the formation of
numerous TIAs via several speciﬁc branches. For example,
one branch of the TIA pathway produces ajmalicine and
serpentine, a second branch leads to production of lochnericine
and hörhammericine, a third branch produces vindoline and
a fourth branch produces catharanthine. The production of
vindoline from tabersonine occurs via seven reactions. Genes
encoding enzymes catalyzing all seven steps have now been
identiﬁed (Vazquez-Flota et al., 1997; St-Pierre et al., 1998;
Schröder et al., 1999; Levac et al., 2008; Liscombe et al.,
2010; Qu et al., 2015). Vindoline and catharanthine are the
substrates for amajor class III peroxidase (PRX1), which catalyzes
formation of α-3′,4′-anhydrovinblastine (Costa et al., 2008).
Vinblastine and vincristine, two of the most pharmaceutically
important TIAs, are formed through multiple steps from α-3′,4′-
anhydrovinblastine.
Transcriptional activators and repressors play important roles
in regulating TIA biosynthesis. Expression of both Octadecanoid-
Responsive Catharanthus AP2-domain protein 2 (ORCA2) and
ORCA3 increases rapidly upon fungal elicitation (Menke et al.,
1999; van der Fits andMemelink, 2000). ORCA2 and ORCA3 are
AP2-domain transcription factors that activate STR expression
through a jasmonate signal transduction pathway by binding
to the jasmonate and elicitor-responsive element (JERE) in the
STR promoter (Menke et al., 1999; van der Fits and Memelink,
2001). ORCA2 (Li et al., 2013) and ORCA3 (van der Fits
and Memelink, 2000; Peebles et al., 2009; Wang et al., 2010;
Zhou et al., 2010b; Tang et al., 2011; Pan et al., 2012; Van
Moerkercke et al., 2015) have also been shown to regulate many
additional TIA biosynthetic and regulatory genes. The levels
of some TIAs are also aﬀected by overexpression of ORCA2
(Liu et al., 2011; Li et al., 2013) and/or ORCA3 (van der
Fits and Memelink, 2000; Peebles et al., 2009; Wang et al.,
2010; Zhou et al., 2010b; Tang et al., 2011; Pan et al., 2012).
BIS1, a basic Helix-Loop-Helix transcription factor, regulates
expression of the genes encoding all of the enzymes necessary
for the conversion of geranyl diphosphate to loganic acid (Van
Moerkercke et al., 2015). The CrMYC2 (basic Helix-Loop-
Helix) transcription factor helps regulate TIA production by
controlling the jasmonate-responsive expression of the ORCA
genes (Zhang et al., 2011). Two AT-hook DNA binding proteins,
2D173 and 2D7, also help regulate ORCA3 expression (Vom
Endt et al., 2007). The CrMYC1 transcription factor helps
regulate STR expression and is responsive to both jasmonate and
elicitor treatments (Chatel et al., 2003). Similarly, the CrWRKY1
and CrWRKY2 transcription factors exert positive regulatory
eﬀects on multiple TIA biosynthetic genes (Suttipanta, 2011;
Suttipanta et al., 2011). However, overexpression of CrWRKY1
and CrWRKY2 has contrasting eﬀects on expression of speciﬁc
TIA regulatory genes. Overexpression of CrWRKY1 results in
decreased transcript levels for the ORCA2, ORCA3, and CrMYC2
TIA transcriptional activators and increased transcript levels
for the ZCT1, ZCT2, and ZCT3 TIA transcriptional repressors
(Suttipanta, 2011), whereas overexpression of CrWRKY2 results
in increased transcript levels for both the ORCA2, ORCA3, and
CrWRKY1 TIA transcriptional activators and the ZCT1 and
ZCT3 TIA transcriptional repressors (Suttipanta et al., 2011). In
addition to transcriptional activators, three zinc ﬁnger proteins,
ZCT1, ZCT2, and ZCT3 (Pauw et al., 2004; Chebbi et al., 2014)
and two G-box-binding factors, GBF1 and GBF2 (Sibéril et al.,
2001) act as transcriptional repressors of speciﬁc genes from the
TIA or TIA feeder pathways.
CrBPF1 was identiﬁed as a protein that binds an element in
the C. roseus STR promoter that is distinct from the element
bound by the ORCAs (van der Fits et al., 2000). CrBPF1
contains a single MYB-like DNA binding domain near its
C-terminus. The presence of a single MYB-like sequence places
CrBPF1 in the R-MYB family of proteins (Feller et al., 2011).
Sequence analysis showed that CrBPF1 has high homology to
the parsley box P-binding factor-1 (BPF-1; da Costa e Silva et al.,
1993), which accumulates rapidly in elicitor-treated parsley cells
and around fungal infection sites on parsley leaves. A strong
correlation between BPF-1 transcript levels and phenylalanine
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FIGURE 1 | Overview of terpenoid indole alkaloid (TIA) biosynthesis in Catharanthus roseus. Enzymes are indicated using capital letters and metabolites
using lowercase letters. Solid arrows indicate single enzymatic conversions; dashed arrows indicate multiple enzymatic reactions. The genes analyzed in this work
are shown in bold type. 16OMT, 16-hydroxytabersonine-O-methyl-transferase; 19H, 19-hydroxylase; AS, anthranilate synthase; CPR, cytochrome P450 reductase;
D4H, desacetoxyvindoline 4-hydroxylase; DAT, deacetylvindoline 4-O-acetyltransferase; DXR, 1-deoxy-D-xylulose-5-phosphate reductoisomerase; DXS,
1-deoxy-D-xylulose-5-phosphate synthase; G10H, geraniol 10-hydroxylase; GES, geraniol synthase; GPPS, geranyl diphosphate synthase; IDI, isopentenyl
diphosphate isomerase; LAMT, loganic acid O-methyltransferase; MAT, minovincinine-19-O-acetyltransferase; NMT, N-methyltransferase; PRX1, vacuolar class III
peroxidase; SGD, strictosidine glucosidase; SLS, secologanin synthase; STR, strictosidine synthase; T3O, tabersonine 3-oxygenase; T3R, tabersonine 3-reductase;
T6,7E, tabersonine 6,7-epoxidase; T16H, tabersonine 16-hydroxylase; T19H, tabersonine/lochnericine19-hydroxylase; TDC, tryptophan decarboxylase.
ammonia-lyase (PAL) expression in parsley cell cultures suggests
that BPF-1 might play an important role in disease resistance
by helping regulate expression of plant defense genes (da Costa
e Silva et al., 1993). In C. roseus CrBPF1 was found to bind
speciﬁcally to the BA element within the STR promoter. CrBPF1
promotes STR transcription through a signal transduction
pathway that is responsive to elicitors but not jasmonate and
acts downstream of protein phosphorylation and calcium inﬂux
(van der Fits et al., 2000). However, current evidence indicates
that CrBFP1 activity is not suﬃcient for elicitor-induced STR
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expression (van der Fits et al., 2000). Deletion of the BA fragment
did not eliminate the ability of the STR promoter to respond to
elicitor or jasmonate, whereas alteration or deletion of the JERE
fragment rendered the STR promoter unable to respond to either
of these compounds (Menke et al., 1999).
Information regarding whether CrBPF1 plays a role in the
regulation of TIA-related genes other than STR has not previously
been reported, leaving the role of CrBPF1 in regulation of TIA
metabolism unknown. To address this issue, a transgenic hairy
root line of C. roseus that overexpresses CrBPF1 under the
control of a β-estradiol inducible promoter was generated. The
transcript levels of 31 TIA biosynthetic and regulatory genes
were tracked over a 72-h period under β-estradiol-induced and
un-induced condition. The levels of 14 metabolites from the
TIA and TIA feeder pathways were also investigated over the
same time course, with nine of those metabolites being present
at detectable levels in the majority of the samples analyzed.
The results of these transcriptional and metabolic proﬁling
experiments have revealed the role of CrBPF1 in regulation of
TIA metabolism.
Materials and Methods
Plant Materials and Growth Conditions
Catharanthus roseus, Vinca Little Bright Eye1, was used for this
work. Seeds were surface sterilized and then germinated on
B5 medium (Sigma, St. Louis, MO, USA) supplemented with
Gamborg’s vitamins (Sigma, St. Louis, MO, USA). Seeds were
germinated in the dark at 26◦C for 2 weeks. The seedlings
were then transferred to a 16-h-light/8-h-dark cycle with a light
intensity of approximately 44 μmol m−2 s−1 for 4 weeks before
inoculation with Agrobacterium tumefaciens.
Generation of CrBPF1 Overexpression
Construct
The pERKT vector (Tsuda et al., 2012) is a modiﬁed version
of the pMDC32 Gateway vector (Curtis and Grossniklaus,
2003) that expresses the XVE chimeric transcriptional activator
(Zuo et al., 2000) under the control of a strong constitutive
promoter. XVE allows estradiol-inducible expression of
genes cloned behind an appropriate promoter sequence (Zuo
et al., 2000). For this work, the full-length CrBPF1 open
reading frame was inserted into pERKT behind a promoter
that allows estradiol-inducible expression by XVE. DNA
containing the CrBPF1 open reading was obtained by PCR
ampliﬁcation of C. roseus cDNAs using KOD Hot Start DNA
polymerase (Novagen, Madison, WI, USA) and the following
primer pair: 5′ ATGGTGTTGAAGAGAAGGC 3′ and 5′
TTAATCCGCCTGAGCATCC 3′. The resulting PCR fragment
was cloned into the pCR8/GW/TOPO entry vector (Invitrogen,
Grand Island, NY, USA) and then transferred to pERKT
by an LR reaction to form pERKT-CrBPF1 (Supplemental
Figure S1).
1www.neseed.com
Generation of Transgenic C. roseus Hairy
Roots
Transformation of 6-weeks old C. roseus was carried out using
an equal mixture of A. tumefaciens cultures transformed with
pERKT-CrBPF1 or the pPZPROL plasmid that carries the
rol ABC genes (Hong et al., 2006), as previously described
(Hong et al., 2006). Hairy roots appeared on infection sites
approximately 4 weeks after inoculation. These hairy roots were
allowed to grow to a length of approximately 1 cm and then
excised and transferred to solid medium supplemented with
30 g L−1 sucrose, 6 g L−1 agar, 250 mg L−1 cefotaxime,
half-strength Gamborg’s B5 salts, and full-strength Gamborg’s
vitamins (pH 5.8). One week after transfer to the above
media, 30 mg L−1 hygromycin was used to select for roots
carrying the pERKT-CrBPF1 construct. Hygromycin-resistant
hairy roots were further screened by PCR using primers
with sequences 5′ ATGATCACAAGCTGATCCCC 3′ and 5′
GTGCGTTCGGAAAAAGAATC 3′ to amplify a DNA sequence
that spans CrBPF1 and adjacent vector sequences within pERKT-
CrBPF1. Transgenic hairy root lines exhibiting hygromycin-
resistance and a positive reaction in the PCR test were transferred
to 50 mL of liquid media containing half-strength Gamborg’s
B5 liquid solution supplemented with full-strength Gamborg’s
vitamins and 30 g L−1 sucrose in a 150-mL ﬂask. Hairy root
cultures were incubated in the dark on a shaker at 225 rpm and
sub-cultured every 5 weeks.
Induction of Transgene Expression and Tissue
Collection
One transgenic hairy root line carrying the pERKT-CrBPF1
overexpression construct (CrBPF1-OE) and one control line
carrying only the pPZPROL transformation construct (Li et al.,
2013) were used for time course analyses. Each transgenic
hairy root culture was started from ﬁve hairy roots that were
3–4 cm in length. These cultures were grown for 35 days and
then transferred to fresh liquid media with 20-μM β-estradiol
(induced cultures) or without β-estradiol (un-induced cultures)
for 0, 6, 12, 24, 48, or 72 h before being harvested. Three separate
cultures were harvested for each hairy root line, time point and
treatment condition. Hairy roots were ﬂash frozen immediately
after harvest using liquid nitrogen and then stored at –80◦C.
Aliquots of the same tissue samples were used for analyses of both
transcript and metabolite levels.
RNA Extraction and qRT-PCR Analyses
Total RNA was isolated using the Spectrum Total RNA Isolation
Kit with on-column DNase 1 digestion (Sigma, St. Louis, MO,
USA), as described (Huang et al., 2010). For quantiﬁcation
of transcripts produced by BIS1, the endogenous and trans
CrBPF1 genes, CrMYC1, CrMYC2, CrWRKY1, CrWRKY2,
DXS1, DXS2B, MAT, T16H2, and T19H the GoScript Reverse
Transcription System (Promega, Madison, WI, USA) was used
to produce cDNAs. These cDNAs were analyzed by qPCR using
the LightCycler 480 SYBR Green I Master mix by Roche and
a Roche LightCycler 480 II (Roche Diagnostics, Indianapolis,
IN, USA). For quantiﬁcation of transcripts produced by all
other genes (including the total transcripts produced by the
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CrBPF1 endogenous and transgenes combined), SuperScript
II reverse transcriptase (Invitrogen, Grand Island, NY, USA)
was used for cDNA synthesis and qPCR was performed
on an ABI 7900 HT (Applied Biosystems, Grand Island,
NY, USA) with a 384-well ABI optical plate using Roche
Universal Probes (Roche Applied Science, USA) and the
Homebrew master mix (University of Minnesota Genomics
Center, Minneapolis, MN, USA). PCR primers and Roche
Universal Probe numbers are described in Supplemental
Table S1. qPCR data were normalized using the geometric
average (Vandesompele et al., 2002) of two control genes,
EF1 and UBQ11, which exhibit particularly stable expression
patterns in C. roseus (Wei, 2010). Diﬀerences in EF1 and
UBQ11 CT levels were typically minor (Supplemental Table
S2). Relative mRNA levels for each gene were converted to
Ct. Ct = Ctun−induced control line at 0 h − Ctother.
Ctun−induced control line at 0 h = CTindicated gene in un−induced
control line at 0 h − CTEF1/UBQ11in un−induced control line at 0 h.
Ctother = CTindicated gene − CTEF1/UBQ11 for the indicated
line, growth condition, and time point. The lone exception is
that mRNA levels for the CrBPF1 transgene were normalized
versus mRNA levels from the endogenous CrBPF1 gene in
the un-induced control line at 0 h rather than against CrBPF1
transgene mRNA levels in the un-induced control line at 0 h
because the control line lacks the CrBPF1 transgene. A positive
Ct value indicates that mRNA levels for the indicated
gene are higher in the indicated hairy root line grown for the
indicated time under the indicated conditions than in the un-
induced control line at 0 h. Negative Ct values indicate the
reverse situation. As the amount of PCR product approximately
doubles with each reaction cycle, a Ct of one corresponds
to approximately a twofold diﬀerence in transcript levels. The
genes analyzed in this study are: 16OMT [GenBank: EF444544],
ASα [GenBank: AJ250008], BIS1 [GenBank: KM409646], CPR
[GenBank: X69791], CrBPF1 [GenBank: AJ251686], CrMYC1
[GenBank: AF283506], CrMYC2 [GenBank: AF283507],
CrWRKY1 [GenBank: HQ646368], CrWRKY2 [GenBank
accession number not available], D4H [GenBank: U71605],
DAT [GenBank: AF053307], DXS1 [GenBank: KC625536],
DXS2A [GenBank: AJ011840], DXS2B [GenBank: DQ8486762],
EF1 [GenBank: EU007436], G10H [GenBank: AJ251269],
GBF1 [GenBank: AF084971], GBF2 [GenBank: AF084972],
LAMT [GenBank: EU057974], MAT [GenBank: AF253415],
ORCA2 [GenBank: AJ238740], ORCA3 [GenBank: EU072424],
PRX1 [GenBank: AM236087], SGD [GenBank: EU072423],
STR [GenBank: X53602], T16H1 [GenBank: FJ647194], T16H2
[GenBank: JF742645], T19H [GenBank: HQ901597], TDC
[GenBank: X67662], UBQ11 [GenBank: EU007433], ZCT1
[GenBank: AJ632082], ZCT2 [GenBank: AJ632083], ZCT3
[GenBank: AJ632084].
Alkaloid Extraction and Analysis
Frozen hairy root tissue samples were lyophilized and ground
to a ﬁne powder. Fifty milligram aliquots of the ground tissue
samples were extracted on ice for 10min using 10mL ofmethanol
and a Model VC 130PB sonicating probe (Sonics & Materials,
Inc., Newton, CT, USA), as previously described (Sander, 2009).
The extracts were centrifuged for 12 min at 4000 rpm at 15◦C.
The biomass was re-extracted as above and the supernatants
combined and passed through a 0.45 μm nylon ﬁlter (25 mm,
PJ Cobert, St Louis, MO, USA). The supernatants were then
dried using a nitrogen evaporator (Organomation Associates,
Inc., Berlin, MA, USA). The residues were dissolved in 2 mL
of methanol, ﬁltered using a 0.22 μm nylon ﬁlter (13 mm, PJ
Cobert) and then stored at –25◦C.
Twenty-microliter aliquots of the extracted alkaloid
concentrate were run on a Phenomenex Luna C18(2)
column (250 mm × 4.6 mm) connected to a Waters high
performance liquid chromatography system [1525 binary
pump, 717plus Autosampler, 996 Photo Diode Array (PDA)
detector] using three diﬀerent solvent systems. TIAs were
examined following a previously described method (Sander,
2009). PDA data extracted at 254 nm were compared to
standards for the quantiﬁcation of strictosidine (gift from Dr.
O’Connor, John Innes Centre, UK), ajmalicine (Fluka/Sigma, St.
Louis, MO, USA), serpentine (Sigma–Aldrich, St. Louis, MO,
USA), vindoline (ChemPaciﬁc Corp., Baltimore, MD, USA),
vincristine (Sigma, St. Louis, MO, USA), vinblastine (Sigma,
St. Louis, MO, USA), and catharanthine (Qventas, Branford,
CT, USA). PDA data extracted at 329 nm were compared to
standards for the quantiﬁcation of tabersonine, lochnericine,
and hörhammericine (all in-house standards). Tryptophan
(Sigma, St. Louis, MO, USA) and tryptamine (Sigma, St. Louis,
MO, USA) were investigated using a previously described
method and PDA data extracted at 218 nm (Peebles et al., 2005).
Loganin (Fluka/Sigma, St. Louis, MO, USA) and secologanin
(Fluka/Sigma, St. Louis, MO, USA) were measured using a
previously describe method and PDA data extracted at 239 nm
(Li et al., 2013).
Promoter Analysis
Catharanthus roseus DNA sequences available in the
Medicinal Plant Genomics Resource2 and NCBI3
databases were screened using BLASTN for sequences
similar to the 16 (CAAAAGTATTATGATT) and 42
(CGCTATTTATCATATAATTATTTTACAATAATTAGTATTA
GG) nucleotide CrBPF1 binding sites (van der Fits et al.,
2000).
Statistical Analyses
A two-tailed Student’s t-test was employed for statistical
analyses. To identify statistically signiﬁcant diﬀerences,
results from β-estradiol induced hairy roots carrying the
CrBPF1 overexpression construct were compared with
results from un-induced hairy roots carrying the CrBPF1
overexpression construct. For qRT-PCR experiments, (∗)
was used to represent p ≤ 0.05 and (∗∗) was used to
represent p ≤ 0.01. For analyses of metabolite levels, (∗)
was used to represent p ≤ 0.1 and (∗∗) was used to represent
p ≤ 0.05.
2http://medicinalplantgenomics.msu.edu/mpgr_blast.shtml#aln2
3https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch
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Results
Generation of Transgenic Hairy Roots
Expressing CrBPF1 under the Control of a
β-Estradiol Inducible Promoter
CrBPF1 was identiﬁed by screening for proteins that bind the
STR promoter. However, information regarding whether CrBPF1
plays a role in the regulation of other TIA or TIA-related
genes is lacking, preventing determination of the role of CrBPF1
in regulation of these pathways. To address this deﬁciency,
C. roseus transgenic hairy root lines that express CrBPF1 under
the control of an estradiol-inducible promoter (Zuo et al., 2000)
were generated. Use of an estradiol-inducible promoter provides
several advantages. An inducible promoter allows the timing and
level of transgene expression to be controlled. This ability allows
transgenic cultures to be grown without transgene expression,
avoiding the possible deleterious consequences of long-term
transgene expression. An inducible system also allows studies on
the transient eﬀects of transgene expression.
To generate transgenic hairy roots, C. roseus seedlings were
inoculated with a mixture of A. tumefaciens cells transformed
with either pERKT-CrBPF1 (Supplemental Figure S1) or
pPZPROL (Hong et al., 2006). A total of 62 hairy root lines were
screened for hygromycin resistance and seven lines were found
to be resistant. These seven hairy root lines were conﬁrmed to
carry the CrBPF1 transgene by using PCR to demonstrate the
presence of a DNA fragment spanning part of the CrBPF1 gene
and an adjacent sequence from the pERKT-CrBPF1 vector. These
positive lines were transferred to liquid culture. Lines with good
adaption to growth in liquid culture were screened for β-estradiol
inducible expression of CrBPF1. As expression of the CrBPF1
transgene is particularly strongly induced by β-estradiol in the
CrBPF1-OE line (Figure 2), and CrBPF1-OE also adapted well to
growth in liquid media, further studies utilized this line.
To characterize β-estradiol inducible expression of CrBPF1,
a time course experiment was performed using the CrBPF1-OE
and control transgenic lines. The transgenic hairy root control
line was generated previously (Li et al., 2013) by transforming
C. roseus with pPZPROL alone, and thus lacks the β-estradiol-
inducible CrBPF1 transgene. The CrBPF1-OE and control lines
were grown for 35 days and then transferred to fresh media
with 0 μM (un-induced) or 20 μM (induced) β-estradiol. Tissue
samples were collected 0, 6, 12, 24, 48, and 72 h after addition
of β-estradiol. CrBPF1 transcripts produced by the CrBPF1
endogenous gene and by the CrBPF1 transgene were quantiﬁed
separately using qRT-PCR (Figure 2). CrBPF1 transgene mRNA
levels increased rapidly in the CrBPF1-OE line after addition
of 20 μM β-estradiol, rising approximately 50 fold within 6 h,
and remained high for at least 72 h. Un-induced cultures of
the CrBPF1-OE line exhibited much lower transcript levels for
the CrBPF1 transgene than the induced cultures, indicating that
β-estradiol is necessary for high-level expression of the CrBPF1
transgene (Figure 2A). As expected, qRT-PCR reactions using a
primer pair speciﬁc for the CrBPF1 transgene produced only a
very low signal from RNA isolated from the control line (data
not shown), which lacks the CrBPF1 transgene. Transcript levels
for the CrBPF1 endogenous gene were not signiﬁcantly aﬀected
FIGURE 2 | Time course analysis of CrBPF1 endogenous and
transgene mRNA levels. CrBPF1 transcripts produced from the
endogenous CrBPF1 gene and the CrBPF1 transgene were quantified
independently by qRT-PCR using primers specific for each gene
(Supplemental Table S1). As expected, the primer pair specific for transcripts
produced by the CrBPF1 transgene yields only a very low background signal
for the control line (data not shown), which lacks the CrBPF1 transgene.
Results depicted are the following: un-induced CrBPF1-OE line (, solid line),
β-estradiol induced CrBPF1-OE line (, solid line), un-induced control line (,
dashed line) and β-estradiol induced control line (, dashed line). (A) Relative
CrBPF1 transgene mRNA levels are indicated as Ct. Note that CrBPF1
transgene mRNA levels were normalized versus CrBPF1 endogenous gene
mRNA levels in the un-induced control line at 0 h rather than against CrBPF1
transgene mRNA levels in the un-induced control line at 0 h as the control line
lacks the CrBPF1 transgene. (B) Relative CrBPF1 endogenous gene mRNA
levels are indicated as Ct. A positive Ct value indicates that CrBPF1
endogenous gene mRNA levels are higher in the indicated hairy root line
grown for the indicated time under the indicated conditions than in the
un-induced control line at 0 h. Negative Ct values indicate the reverse
situation. Results are the average Ct of three biological replicates, with two
technical replicates per biological replicate. Error bars indicate SD. CrBPF1
mRNA levels in the un-induced versus induced CrBPF1-OE cultures differed
at the same time point with: ∗p ≤ 0.05, ∗∗p ≤ 0.01 according to a Student’s
t-test. The results of Student’s t-tests for the un-induced versus induced
cultures of the control line are not depicted.
by treatment with β-estradiol and were similar in the CrBF1-OE
and control lines (Figure 2B).
Effects of CrBPF1 Overexpression on the
Indole and Terpenoid Pathways
CrBPF1 is one of only a few putative activators of the TIA
pathway identiﬁed to date. Understanding the role played by
CrBPF1 in regulation of the TIA pathway is important for
developing strategies for in vivomanipulation of TIA production.
Toward this end, the eﬀects of CrBPF1 overexpression on
transcript levels of 31 genes were analyzed. The genes chosen
for analysis include two genes from the indole pathway (ASα
and TDC), six genes from the monoterpenoid pathway (DXS1,
DXS2A, DXS2B, G10H, CPR, and LAMT) and ten genes from the
TIA pathway (STR, SGD, T16H1, T16H2, 16OMT, D4H, DAT,
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PRX1, T19H, and MAT). In addition, transcript levels of all of
the cloned genes currently postulated to play a role in regulation
of the TIA pathway were characterized. These genes include
eight TIA transcriptional activators (ORCA2, ORCA3, CrBPF1,
CrMYC1, CrMYC2, CrWRKY1, CrWRKY2, and BIS1) and ﬁve
TIA transcriptional repressors (ZCT1, ZCT2, ZCT3, GBF1, and
GBF2). In addition, the concentrations of 14 TIA metabolites
were investigated, with nine of those metabolites being present
at detectable levels. Both transcript and metabolite levels were
tracked over a 72-h period in the CrBPF1-OE and control lines
grown in the absence or presence of β-estradiol.
The production of TIAs is dependent on the synthesis of
tryptamine in the indole pathway, the synthesis of secologanin
in the terpenoid pathway and their subsequent coupling to
form strictosidine. Thus, it was of interest to determine whether
overexpression of CrBPF1 aﬀects expression of genes in the
indole or terpenoid pathways. To characterize the eﬀects of
overexpressing CrBPF1 on the indole pathway, ASα and TDC
transcripts were quantiﬁed. ASα encodes the alpha subunit of
anthranilate synthase, which catalyzes the ﬁrst committed step
in tryptophan synthesis. Overexpression of CrBPF1 caused a
signiﬁcant increase in ASα transcript levels. ASα transcript levels
were slightly higher in the induced versus un-induced CrBPF1-
OE cultures 6 h after addition of β-estradiol, and reached a
peak at the 12-h time point before beginning to decline. In
contrast, addition of β-estradiol to the media had no signiﬁcant
eﬀect on ASα transcript levels in the control line (Figure 3A).
TDC encodes tryptophan decarboxylase, which catalyzes the
formation of tryptamine from tryptophan. TDC transcript levels
were higher in the induced versus un-induced CrBPF1-OE
cultures 12 and 72 h after addition of β-estradiol. However,
overexpression of CrBPF1 caused only slight diﬀerences in TDC
transcript levels, with a maximum diﬀerence of 75% higher
transcript levels in the induced versus un-induced CrBPF1-OE
cultures at the 12-h time point. Addition of β-estradiol to the
FIGURE 3 | Time course analysis of ASα and TDCmRNA levels. Results
depicted are the following: un-induced CrBPF1-OE line (, solid line),
β-estradiol induced CrBPF1-OE line (, solid line), un-induced control line (,
dashed line) and β-estradiol induced control line (, dashed line). Relative
transcript levels are presented as Ct. Results shown are the following:
(A) ASα mRNA levels and (B) TDC mRNA levels. Results are the average
Ct values of three biological replicates with two technical replicates per
biological replicate. Error bars indicate SD. Transcript levels in the un-induced
versus induced CrBPF1-OE cultures differed at the same time point with:
∗p ≤ 0.05, ∗∗p ≤ 0.01 according to a Student’s t-test. The results of Student’s
t-tests for the un-induced versus induced cultures of the control line are not
depicted.
media had no signiﬁcant eﬀect on TDC transcript levels in the
control line (Figure 3B). An attempt was also made to analyze
tryptophan and tryptamine levels in aliquots of the same tissue
samples used to analyze gene expression. However, tryptophan
and tryptamine levels were below the detection threshold inmany
of the samples.
The expression levels of six genes in the terpenoid pathway
were determined. Three of these genes (DXS1, DXS2A, and
DXS2B) encode diﬀerent isoforms of 1-deoxy-D-xylulose 5-
phosphate synthase. DXS2A and DXS2B are induced by ORCA3
overexpression, whereas DXS1 is not regulated by ORCA3 (Han
et al., 2013). Overexpression of CrBPF1 had only a very modest
eﬀect on expression of the DXS genes. DXS1 expression was 70%
lower in the induced versus un-induced CrBPF1-OE cultures at
the 72-h time point, but was not signiﬁcantly altered at the other
time points assayed. Addition of β-estradiol had a very slight
eﬀect on DXS1 expression in the control line, causing a 6 to
30% increase in DXS1 transcript levels at the 6, 12, and 72-h
time points (Figure 4A). DXS2A expression was slightly induced
by β-estradiol at the 12-h time point in the CrBPF1-OE line
(Figure 4B). DXS2B transcript levels were increased 1.6 and 2.0
fold in the induced versus un-induced CrBPF1-OE cultures at the
6 and 12-h time points, respectively. However,DXS2B expression
was also induced 1.5X in the induced versus un-induced control
cultures at the 6-h time point, suggesting that application of
β-estradiol, rather than increased CrBPF1 expression, might
be responsible for the alterations in DXS2B transcript levels
(Figure 4C). G10H transcript levels were signiﬁcantly higher in
the induced versus un-induced CrBPF1-OE cultures at the 6,
12, and 72-h time points, but the diﬀerences in transcript levels
were slight, reaching a maximum diﬀerence of less than twofold
at the 12-h time point (Figure 4D). CPR transcript levels were
signiﬁcantly higher in the induced versus un-induced CrBPF1-
OE cultures at the 12, 48, and 72-h time points, but the diﬀerences
in transcript levels were slight, with a maximum diﬀerence of
approximately 1.5 fold at the 48-h time point (Figure 4E).
LAMT transcript levels were approximately 2.5 fold higher in
the induced versus un-induced CrBPF1-OE cultures at the 12-
h time point, but were not signiﬁcantly diﬀerent at the other
time points analyzed (Figure 4F). Addition of β-estradiol had no
signiﬁcant eﬀects on transcript levels of G10H, CPR, or LAMT in
the control line. The levels of loganin and secologanin were also
determined in aliquots of the same tissue samples used for gene
expression analyses. The addition of 20-μM β-estradiol to the
media caused no substantial alterations in the levels of either of
these metabolites over the time period analyzed (Figures 4G,H).
Effects of CrBPF1 Overexpression on TIA
Biosynthetic Gene mRNA Levels
To characterize the eﬀects of overexpressing CrBPF1 on the TIA
pathway, transcript levels of ten TIA biosynthetic genes were
characterized. STR and SGD encode the enzymes that catalyze
the ﬁrst two steps in TIA biosynthesis. Overexpression of CrBPF1
had no signiﬁcant eﬀects on STR transcript levels (Figure 5A).
SGD transcript levels were 75% higher in the induced versus
un-induced CrBPF1-OE cultures at the 12-h time point, but
were not signiﬁcantly altered by CrBPF1 overexpression at the
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FIGURE 4 | Time course analyses of transcript and metabolite levels
from the terpenoid pathway. Results depicted are the following:
un-induced CrBPF1-OE line (, solid line), β-estradiol induced CrBPF1-OE
line (, solid line), un-induced control line (, dashed line) and β-estradiol
induced control line (, dashed line). Relative transcript levels are presented
as Ct. Results shown are the following: (A) DXS1 mRNA levels, (B) DXS2A
mRNA levels, (C) DXS2B mRNA levels, (D) G10H mRNA levels (E) CPR
mRNA levels, (F) LAMT mRNA levels, (G) loganin levels, and (H) secologanin
levels. Results for transcript levels are the average Ct values of three
biological replicates with two technical replicates per biological replicate.
Results for metabolite levels are the averages of three biological replicates.
Metabolite levels for the control line are not depicted. Error bars indicate SD.
Transcript levels in the un-induced versus induced CrBPF1-OE cultures
differed at the same time point with: ∗p ≤ 0.05, ∗∗p ≤ 0.01 according to a
Student’s t-test. The results of Student’s t-tests for the un-induced versus
induced cultures of the control line are not depicted. Metabolite levels in the
un-induced versus induced CrBPF1-OE cultures differed at the same time
point with: ∗p ≤ 0.1, ∗∗p ≤ 0.05 according to a Student’s t-test.
other time points assayed (Figure 5B). T16H, 16OMT, D4H,
and DAT encode enzymes that catalyze diﬀerent steps in the
pathway leading from tabersonine to formation of vindoline.
Overexpression of CrBPF1 had no signiﬁcant eﬀects on T16H1
(Figure 5C) or T16H2 (Figure 5D) transcript levels. 16OMT
transcript levels were 2.6-fold higher in induced versus un-
induced CrBPF1-OE cultures at the 12-h time point, but were
not signiﬁcantly altered by CrBPF1 overexpression at the other
FIGURE 5 | Time course analysis of TIA biosynthetic gene mRNA
levels. Results depicted are the following: un-induced CrBPF1-OE line (,
solid line), β-estradiol induced CrBPF1-OE line (, solid line), un-induced
control line (, dashed line) and β-estradiol induced control line (, dashed
line). Relative transcript levels are presented as ??Ct. Results shown are the
following: (A) STR mRNA levels, (B) SGD mRNA levels (C) T16H1 mRNA
levels, (D) T16H2 mRNA levels, (E) 16OMT mRNA levels, (F) D4H mRNA
levels, (G) DAT mRNA levels, (H) PRX1 mRNA levels, (I) T19H mRNA levels
and (J) MAT mRNA levels. Results are the average Ct values of three
biological replicates with two technical replicates per biological replicate. Error
bars indicate SD. Transcript levels in the un-induced versus induced
CrBPF1-OE cultures differed at the same time point with: ∗p ≤ 0.05,
∗∗p ≤ 0.01 according to a Student’s t-test. The results of Student’s t-tests for
the un-induced versus induced cultures of the control line are not depicted.
time points assayed (Figure 5E). D4H transcript levels were
signiﬁcantly higher in the induced versus un-induced CrBPF1-
OE cultures at the 12 and 48-h time points, but not at the
other time points analyzed (Figure 5F). The eﬀects of CrBPF1
overexpression on DAT transcript levels were more complex.
Frontiers in Plant Science | www.frontiersin.org 8 October 2015 | Volume 6 | Article 818
Li et al. CrBPF1 affects TIA gene expression
DAT transcript levels were approximately 3-fold higher in the
induced versus un-induced CrBPF1-OE cultures at the 12-h
time point, but were almost twofold lower in the induced
versus un-induced CrBPF1-OE cultures at the 48-h time point.
Interestingly, DAT transcript levels in the CrBPF1-OE line were
consistently below those in the control line (Figure 5G). PRX1
encodes a vacuolar class III peroxidase that catalyzes the synthesis
of α-3′, 4′-anhydrovinblastine from catharanthine and vindoline.
Overexpression of CrBPF1 had no signiﬁcant eﬀects on PRX1
transcript levels (Figure 5H). T19H transcript levels were 2.3-
fold higher in induced versus un-induced CrBPF1-OE cultures at
the 48-h time point, but were not signiﬁcantly altered by CrBPF1
overexpression at the other time points assayed (Figure 5I).
Overexpression of CrBPF1 had no signiﬁcant eﬀects on MAT
transcript levels (Figure 5J). Addition of β-estradiol to the media
had little eﬀect on TIA biosynthetic gene expression in the control
line. Where TIA biosynthetic gene transcript levels did vary
between control cultures grown in the presence of 0 versus 20μM
β-estradiol, transcript levels were typically higher in the cultures
grown on 0μM β-estradiol. For example, T16H1 transcript levels
at the 48-h time point and DAT and PRX1 transcript levels at
the 24-h time point were higher in control cultures grown on
0 μM β-estradiol than on 20 μM β-estradiol (Figure 5). These
results are in contrast to the results observed for the CrBPF1-
OE cultures, where addition of 20-μM β-estradiol to the media
tended to cause increased transcript levels.
Effects of CrBPF1 Overexpression on TIA
Metabolite Levels
As CrBPF1 overexpression aﬀects the transcript levels of many
of the genes involved in synthesis of TIAs or TIA precursors,
it was of interest to determine whether overexpression of
CrBPF1 aﬀects TIA metabolite levels. Toward that end, the
levels of ten TIA metabolites were analyzed over a 72-h period
in the CrBPF1-OE line grown in the presence or absence
of 20-μM β-estradiol, with seven of those metabolites being
present at detectable levels (Figure 6). The metabolites analyzed
were tabersonine, lochnericine, hörhammericine, catharanthine,
serpentine, ajmalicine, strictosidine, vindoline, vincristine, and
vinblastine, with the levels of the last three being below the
detection threshold. Overexpression of CrBPF1 had only modest
eﬀects on the levels of the other seven metabolites, with the
largest statistically signiﬁcant eﬀect being∼40% lower serpentine
levels in the induced versus un-induced CrBPF1-OE cultures at
the 12-h time point. The levels of the same metabolites were
also analyzed in the control line, at 0 and 24 h after transfer to
fresh media with 0 or 20 μM β-estradiol. Addition of 20-μM
β-estradiol to the media had little eﬀect on the levels of any of the
TIA metabolites analyzed in the control line (data not shown).
Effects of CrBPF1 Overexpression on TIA
Regulatory Genes
In addition to regulating expression of biosynthetic genes
directly, a transcriptional regulator may aﬀect expression
of biosynthetic genes by altering the activities of other
transcriptional regulators. To determine whether overexpression
of CrBPF1 aﬀects the activities of TIA transcriptional regulators,
FIGURE 6 | Time course analysis of TIA metabolite levels. Results
depicted are the following: un-induced CrBPF1-OE line (, solid line) and
β-estradiol induced CrBPF1-OE line (, solid line). Metabolite levels shown
are the following: (A) tabersonine levels, (B) lochnericine levels
(C) hörhammericine levels, (D) catharanthine levels, (E) serpentine levels,
(F) ajmalicine levels and (G) strictosidine levels. Results are the average values
of three biological replicates. Error bars indicate SD. Metabolite levels in the
un-induced versus induced CrBPF1-OE cultures differed at the same time
point with: ∗p ≤ 0.1 according to a Student’s t-test.
transcript levels for all the postulated TIA regulators for
which genes have been cloned were analyzed in CrBPF1-
OE and control cultures grown on 0 or 20 μM β-estradiol.
Currently, eight transcriptional activators (ORCA2, ORCA3,
CrBPF1, CrMYC1, CrMYC2, CrWRKY1, CrWRKY2, and BIS1)
and ﬁve transcriptional repressors (ZCT1, ZCT2, ZCT3, GBF1,
and GBF2) are postulated to function in regulation of the TIA
pathway. Overexpression of CrBPF1 had little eﬀect on ORCA2
transcript levels, with the only statistically signiﬁcant eﬀect
being an approximately 60% increase in ORCA2 transcript levels
in the induced versus un-induced CrBPF1-OE cultures at the
48-h time point (Figure 7A). Overexpression of CrBPF1 had
a more consistent eﬀect on ORCA3 expression, with ORCA3
transcript levels being signiﬁcantly higher in the induced versus
un-induced CrBPF1-OE cultures at the 6, 12, and 48-h time
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FIGURE 7 | Time course analysis of TIA regulatory gene mRNA levels.
Results depicted are the following: un-induced CrBPF1-OE line (, solid line),
β-estradiol induced CrBPF1-OE line (, solid line), un-induced control line (,
dashed line) and β-estradiol induced control line (, dashed line). Relative
transcript levels are presented as Ct. Results shown are the following:
(A) ORCA2 mRNA levels, (B) ORCA3 mRNA levels (C) CRMYC1 mRNA
levels, (D) CrMYC2 mRNA levels, (E) CrWRKY1 mRNA levels, (F) CrWRKY2
mRNA levels, (G) BIS1 mRNA levels, (H) ZCT1 mRNA levels, (I) ZCT2 mRNA
levels, (J) ZCT3 mRNA levels, (K) GBF1 mRNA levels and (L) GBF2 mRNA
levels. Results are the average Ct values of three biological replicates with
two technical replicates per biological replicate. Error bars indicate SD.
Transcript levels in the un-induced versus induced CrBPF1-OE cultures
differed at the same time point with: ∗p ≤ 0.05, ∗∗p ≤ 0.01 according to a
Student’s t-test. The results of Student’s t-tests for the un-induced versus
induced cultures of the control line are not depicted.
points, reaching a maximum diﬀerence of 2.4 fold at the 48-h
time point (Figure 7B). To determine whether CrBPF1 aﬀects its
own expression, transcripts produced by the endogenous CrBPF1
gene were analyzed in the CrBPF1-OE and control lines grown
on 0 or 20 μM β-estradiol. Increased expression of the CrBPF1
transgene had no signiﬁcant eﬀect on CrBPF1 endogenous gene
transcript levels, indicating that CrBPF1 does not regulate its own
expression at the steady-state transcriptional level (Figure 2B).
CrMYC1 transcript levels were almost fourfold higher in induced
versus un-induced CrBPF1-OE cultures at the 6 and 12-h time
points, but were not signiﬁcantly altered at later time points
(Figure 7C). Overexpression of CrBPF1 had smaller, but more
consistent eﬀects on CrMYC2 transcript levels, with 30–60%
higher CrMYC2 transcript levels in the induced versus un-
induced CrBPF1-OE cultures at all time points assayed, except
for the latest time point (Figure 7D). Overexpression of CrBPF1
also had a modest eﬀect on CrWRKY1 transcript levels, which
exhibited statistically signiﬁcant 30% increases in the induced
versus un-induced CrBPF1-OE cultures at the 12 and 48-h time
points (Figure 7E). In contrast, overexpression of CrBPF1 had
no statistically signiﬁcant eﬀects on CrWRKY2 transcript levels
(Figure 7F). Overexpression of CrBPF1 caused a statistically
signiﬁcant 60% increase in BIS1 transcript levels at the 12-h time
point and a 20% increase at the 72-h time point (Figure 7G).
Overexpression of CrBPF1 had a comparatively large eﬀect on
expression of the ZCT1 transcriptional repressor. ZCT1 transcript
levels were twofold to threefold higher in the induced versus un-
induced CrBPF1-OE cultures at all time points assayed, except
for the earliest, 6-h, time point (Figure 7H). Overexpression of
CrBPF1 also caused signiﬁcant increases in ZCT2 (Figure 7I)
and ZCT3 (Figure 7J) expression levels at the 12, 48, and 72-h
time points. Overexpression ofCrBPF1 caused a larger increase in
ZCT3 than in ZCT2 transcript levels, with ZCT3 transcript levels
being approximately 2–2.5 fold higher in the induced versus
un-induced CrBPF1-OE cultures, as opposed to approximately
1.25–2 fold increases in ZCT2 transcript levels. Overexpression
of CrBPF1 had modest, but fairly consistent, eﬀects on GBF1
expression. GBF1 transcript levels were signiﬁcantly higher in
the induced versus un-induced CrBPF1-OE cultures at all time
points assayed, except for the 24-h time point, where the mean
GBF1 transcript levels were higher in the induced than in the
un-induced CrBPF1-OE cultures, but the diﬀerence was not
statistically signiﬁcant (Figure 7K). Overexpression of CrBPF1
had only a very slight eﬀect on GBF2 transcript levels, with the
only statistically signiﬁcant diﬀerence being an approximately
40% increase in GBF2 transcript levels in the induced versus
the un-induced CrBPF1-OE cultures at the 12-h time point
(Figure 7L). Addition of 20-μM β-estradiol to the media had
little eﬀect on expression of TIA regulatory genes in the control
cultures.
TIA Promoter Analysis
DNase1 ﬁngerprinting resulted in the identiﬁcation of 16 and
42 nt CrBPF1 binding sites within the BA fragment of the
C. roseus STR promoter (van der Fits et al., 2000). C. roseusDNA
sequences available in the Medicinal Plant Genomics Resource2
andNCBI3 databases were searched using BLASTN for sequences
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similar to these 16 and 42-nucleotide CrBPF1 binding sites.
Examination of the top 50matches for the 16 and 42-nt sequences
from the Medicinal Plant Genomics Resource did not reveal
any matches to promoter sequences from genes believed to be
involved in TIA biosynthesis, with the exception of STR. In
contrast, searches of the sequences available in GenBank revealed
several partial matches to the 5′ regions of genes involved in
TIA biosynthesis. The best matches to sequences lying within
approximately 1,500 bp 5′ of a transcription start site are listed
in Supplemental Table S3. In addition to STR, partial matches
for both the 16 and 42-nt sequences were found for ORCA3 and
TDC. However, the spacing between these partial matches was
much larger for ORCA3 and TDC than for STR. The 5′ ends of
the 16 and 42 nt sequences are 70 bp apart in the STR promoter,
but are 365 and 552 bp apart in the ORCA3 and TDC promoters,
respectively. Partial matches to the 16 nt sequence, but not to the
42 nt sequence, were found for CPR, PRX1, BIS1, and CrWRKY1.
A partial match to the 42 nt sequence, but not to the 16 nt
sequence, was found for DXS2B.
Discussion
CrBPF1 was identiﬁed as a MYB-like protein that binds the BA
region of the C. roseus STR promoter (van der Fits et al., 2000).
Although thirteen transcriptional regulators have been postulated
to act in regulation of the TIA pathway, the eﬀects of most of these
transcriptional regulators on expression of the majority of the
known TIA biosynthetic and regulatory genes have not yet been
determined. To address this deﬁciency, a C. roseus transgenic
hairy root line that expresses CrBPF1 under the control of a
β-estradiol inducible promoter was generated and characterized.
Addition of β-estradiol to the medium causes a large and rapid
induction of CrBPF1 transgene expression in the CrBPF1-OE line
but does not aﬀect CrBPF1 expression in a control line, indicating
that the presence of the transgene is necessary for increased
CrBPF1 transcript levels.
Terpenoid indole alkaloid production is dependent on the
synthesis of precursors by both the indole and terpenoid
pathways, the combination of these precursors by STR and
subsequent reactions carried out by diﬀerent branches of the
TIA pathway. Overexpression of CrBPF1 caused increased
expression of the majority of the genes analyzed from these
pathways. However, these eﬀects were typically transient and
of limited magnitude. Interestingly, CrBPF1 overexpression may
cause decreases in DAT expression. Although overexpression of
CrBPF1 caused increased DAT transcript levels after 12 h, DAT
transcript levels decreased after 48 h. In addition, DAT transcript
levels were consistently lower in the CrBPF1-OE line than in
the control line over the entire time course, suggesting that
increased CrBPF1 expression tends to have a negative eﬀect on
DAT activity. Interestingly, DAT expression has been shown to
be strongly decreased in response to overexpression of ORCA2
(Li et al., 2013). The ﬁnding that CrBPF1 overexpression does
not have a signiﬁcant eﬀect on STR transcript levels might appear
somewhat unexpected, given that CrBPF1 is known to bind the
STR promoter (van der Fits et al., 2000). However, this ﬁnding
is consistent with previous work suggesting that CrBPF1 might
have only a limited eﬀect on STR expression (van der Fits et al.,
2000). Binding of CrBPF1 to the STR promoter is only part
of the process promoting STR transcription, with binding of
additional factors to other cis sequences playing an important
role in regulation of STR activity (van der Fits et al., 2000; Chatel
et al., 2003). Consequently, overexpression of CrBPF1 alone
is insuﬃcient to cause signiﬁcant alterations in STR transcript
levels.
To determine whether overexpression of CrBPF1 aﬀects
the expression of other regulators, transcript levels for all
genes postulated to encode TIA regulators were analyzed.
Overexpression of CrBPF1 caused increased expression of all
of the other TIA transcriptional activators except CrWRKY2.
In addition, expression of the CrBPF1 transgene did not aﬀect
expression of the CrBPF1 endogenous gene, indicating that
CrBPF1 does not regulate its own expression. Interestingly,
overexpression of CrBPF1 also caused increased transcript levels
for all ﬁve of the genes postulated to encode TIA transcriptional
repressors. These results suggest that CrBPF1 overexpression
could be altering the transcript levels of some of the biosynthetic
genes characterized indirectly, by altering the activities of other
TIA regulatory genes. The results of a promoter analysis are
consistent with this possibility. Partial matches for both the
16 and 42-nt CrBPF1 binding sites from the STR promoter
were found in the promoters of only ORCA3 and TDC, among
the genes analyzed as part of this study. However, the spacing
between these partial matches was much greater for ORCA3
and TDC than for STR. Partial matches to the 16-nt CrBPF1
binding sequence were also found for the CPR, PRX1, BIS1, and
CrWRKY1 promoters and to the 42-nt sequence for DXS2B.
As CrBPF1 overexpression aﬀects the activities of several
TIA biosynthetic genes and of most of the TIA regulatory
genes analyzed, it was of interest to determine whether CrBPF1
overexpression also aﬀects TIA metabolite levels. Toward that
end the levels of 14 metabolites from diﬀerent parts of the TIA
and feeder pathways were analyzed, with the levels of nine of
those metabolites being above the detection threshold. The results
of these analyses indicate thatCrBPF1 overexpression causes only
slight, and transient, alterations in lochnericine, hörhammericine
and serpentine levels, typically causing decreased levels of these
metabolites. Lochnericine is the precursor for synthesis of
hörhammericine, suggesting that ﬂux to this branch of the TIA
pathway may be altered by CrBPF1 overexpression. Serpentine
is synthesized via a diﬀerent branch of the TIA pathway.
The relatively minor eﬀects of CrBPF1 overexpression on TIA
metabolite levels may be due to the fact that, although CrBPF1
overexpression increases the activities of many TIA and related
genes, these increases in gene expression are typically of limited
magnitude and duration.
The results of this work indicate that although CrBPF1
regulates a high percentage of the genes analyzed, the eﬀects
of CrBPF1 overexpression on gene activity levels tend to be
of comparatively limited magnitude and are often transient.
These modest alterations in TIA biosynthetic gene expression
may help explain the limited eﬀects of CrBPF1 overexpression
on the levels of the TIA metabolites analyzed. The relatively
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minor increases in gene expression may be due to the fact
that CrBPF1 overexpression causes increased expression of
all ﬁve TIA transcriptional repressors, in addition to causing
increased activity of most of the TIA transcriptional activators. In
contrast, overexpression of ORCA2 (Li et al., 2013) and ORCA3
(Peebles et al., 2009) causes increased expression of the ZCT
transcriptional repressors, but not of the GBF transcriptional
repressors. As overexpression of CrBPF1 has comparatively
large eﬀects on expression of TIA transcriptional repressors,
future characterization of these repressors is expected to yield
further insight into the mechanism by which CrBPF1 helps
regulate the TIA and related pathways. The simultaneous
activation of transcriptional repressors and activators has been
proposed to act as part of a “ﬁne tune” mechanism for
regulating TIA production (Memelink and Gantet, 2007). The
ﬁndings reported here support this model and suggest that
CrBPF1 plays a role in the “ﬁne tune” regulation of TIA
metabolism.
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